Does anyone have any experience with SNP calling using GATK and exome sequencing data (illumina paired end)? We tried to run it through normally, like it was whole genome sequence and we did not get any SNPs called (the reads were aligned using bwa). Do we need to do anything with exome positions vs just the whole genome using an option like -L? Any help would be appreciated.
-
-
I get plenty of SNPs in an Illumina sequenced, bwa aligned exome with GATK, and I don't use intervals to restrict calling to the bait/target positions.
Care to share your workflow? Hard to diagnose otherwise.Last edited by Bukowski; 07-10-2012, 11:46 AM. -
We did alignment using bwa run as default. We then used samtools to convert to bam and sort. Then we ran the file through picard AddOrReplaceReadGroups to fix the read groups so that GATK would like it. Then we ran the file through GATK using the UnifiedGenotyper using default options. Our GATK isn't the newest version. Is there an issue with older versions of GATK?Comment
-
There are many issues with old versions of GATK, but having used most of them 'not calling genotypes' isn't one of them. Which version? Can you please post your UnifiedGenotyper command line?Originally posted by ercfrtz View Post
To reiterate it is impossible to diagnose issues where you do not post what you're doing.
The first thing to do though is to update GATK, if you attempt to go for support on https://getsatisfaction.com/gsa it is the first thing they will tell you to do.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM
Comment